Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
PANLAR consensus statement on biosimilars.
Kowalski SC, Benavides JA, Roa PAB, Galarza-Maldonado C, Caballero-Uribe CV, Soriano ER, Pineda C, Azevedo VF, Avila-Pedretti G, Babini AM, Cachafeiro-Vilar A, Cifuentes-Alvarado M, Cohen SB, Díaz PE, Soto LD, Encalada C, Garro B, Sariego IAG, Guibert-Toledano M, Rodriguez VJK, Lopez MEL, Ortega AP, Russell AS, Santos-Moreno P, Terán IS, Vargas A, Vásquez G, Xavier RM, Firedman DXX, Mysler E, Kay J. Kowalski SC, et al. Clin Rheumatol. 2019 May;38(5):1485-1496. doi: 10.1007/s10067-019-04496-3. Epub 2019 Mar 27. Clin Rheumatol. 2019. PMID: 30915652
Correction to: PANLAR consensus statement on biosimilars.
Kowalski SC, Benavides JA, Beltrán PA, Galarza-Maldonado C, Caballero-Uribe CV, Soriano ER, Pineda C, Azevedo VF, Avila-Pedretti G, Babini AM, Cachafeiro-Vilar A, Cifuentes-Alvarado M, Cohen SB, Díaz PE, Diaz-Coto JF, Encalada C, Garro B, Sariego IAG, Guibert-Toledano M, Rodriguez VJK, Lopez MEL, Ortega AP, Russell AS, Santos-Moreno P, Terán IS, Vargas A, Vásquez G, Xavier RM, Firedman DXX, Mysler E, Kay J. Kowalski SC, et al. Clin Rheumatol. 2019 Jul;38(7):2021-2022. doi: 10.1007/s10067-019-04592-4. Clin Rheumatol. 2019. PMID: 31111361
Use of rituximab for the treatment of rheumatoid arthritis: the Latin American context.
Soriano ER, Galarza-Maldonado C, Cardiel MH, Pons-Estel BA, Massardo L, Caballero-Uribe CV, Achurra-Castillo AF, Barile-Fabris LA, Chávez-Corrales J, Díaz-Coto JF, Esteva-Spinetti MH, Guibert-Toledano M, Palazuelos FI, Keiserman MW, Lomonte AV, Mota LM, Pineda Villaseñor C, Alarcón GS; GLADAR (Grupo Latino Americano de Estudio de Artritis Reumatoide). Soriano ER, et al. Rheumatology (Oxford). 2008 Jul;47(7):1097-9. doi: 10.1093/rheumatology/ken015a. Epub 2008 May 7. Rheumatology (Oxford). 2008. PMID: 18463144 No abstract available.
The fibromyalgia problem. A Latin American point of view.
Caballero-Uribe CV. Caballero-Uribe CV. Rheumatology (Oxford). 2004 Oct;43(10):1311-3; author reply 1313-4. doi: 10.1093/rheumatology/keh280. Rheumatology (Oxford). 2004. PMID: 15448219 No abstract available.
Characteristics of emerging new autoimmune diseases after COVID-19 vaccination: A sub-study by the COVAD group.
Shumnalieva R, Ravichandran N, Hannah J, Javaid M, Darooka N, Roy D, Gonzalez DE, Velikova T, Milchert M, Kuwana M, Joshi M, Gracia-Ramos AE, Boyd P, Yaadav P, Cheng K, Kobert L, Cavagna L, Sen P, Day J, Makol A, Gutiérrez CET, Caballero-Uribe CV, Saha S, Parodis I, Dey D, Nikiphorou E, Distler O, Kadam E, Tan AL, Shinjo SK, Ziade N, Knitza J, Chinoy H, Aggarwal R, Agarwal V, Gupta L; COVAD Study Group. Shumnalieva R, et al. Among authors: caballero uribe cv. Int J Rheum Dis. 2024 May;27(5):e15178. doi: 10.1111/1756-185X.15178. Int J Rheum Dis. 2024. PMID: 38742751
Listening to patients, for the patients: The COVAD Study-Vision, organizational structure, and challenges.
Joshi M, Darooka N, Saha S, Dyball S, Sen P, Yaadav P, Javaid M, Kadam E, Shinjo SK, Dey D, Cavagna L, Makol A, Gutiérrez CET, Caballero Uribe CV, Kuwana M, Burmester GR, Ziade N, Wincup C, Andreoli L, Parodis I, Tan AL, Guillemin F, Knitza J, Wang G, Dalbeth N, Velikova T, Gracia-Ramos AE, Nikiphorou E, Day J, Chinoy H, Aggarwal R, Agarwal V, Gupta L; COVAD study group. Joshi M, et al. Among authors: caballero uribe cv. Int J Rheum Dis. 2024 May;27(5):e15161. doi: 10.1111/1756-185X.15161. Int J Rheum Dis. 2024. PMID: 38720408
Impaired health-related quality of life in idiopathic inflammatory myopathies: a cross-sectional analysis from the COVAD-2 e-survey.
Yoshida A, Li Y, Maroufy V, Kuwana M, Sazliyana Shaharir S, Makol A, Sen P, Lilleker JB, Agarwal V, Kadam E, Akawatcharangura Goo P, Day J, Milchert M, Chen YM, Dey D, Velikova T, Saha S, Edgar Gracia-Ramos A, Parodis I, Nikiphorou E, Tan AL, Nune A, Cavagna L, Toro Gutiérrez CE, Caballero-Uribe CV, Saavedra MA, Shinjo SK, Ziade N, El Kibbi L, Knitza J, Distler O, Chinoy H, Agarwal V, Aggarwal R, Gupta L; COVAD Study Group. Yoshida A, et al. Among authors: caballero uribe cv. Rheumatol Adv Pract. 2024 Mar 4;8(2):rkae028. doi: 10.1093/rap/rkae028. eCollection 2024. Rheumatol Adv Pract. 2024. PMID: 38524696 Free PMC article.
Breakthrough SARS-CoV-2 infection and disease flares in patients with rheumatoid arthritis: result from COVAD e-survey study.
Santos CS, Chen JP, Nikiphorou E, Tseng CW, Gutiérrez CET, Tan AL, Nune A, Kadam E, Kuwana M, Day J, Saha S, Velikova T, Lilleker JB, Caballero-Uribe CV, Sen P, Chinoy H, Aggarwal R, Agarwal V, Gupta L, Chen YM; COVAD study group. Santos CS, et al. Among authors: caballero uribe cv. Rheumatol Int. 2024 May;44(5):805-817. doi: 10.1007/s00296-024-05542-3. Epub 2024 Mar 12. Rheumatol Int. 2024. PMID: 38470502
47 results